Antibody drug conjugates: Tackling the unsolved challenges with novel technologies
Antibody drug conjugates (ADCs) represent a promising new generation of cancer therapeutics and a significant advance in targeted drug delivery. …
Post
-
-
Callio raises $187m for proof-of-concept for dual-payload ADC
Callio Therapeutics has raised $187m in a Series A financing round to achieve clinical proof-of-concept for its human epidermal growth …
-
Are European biopharma manufacturers ‘nearshoring’?
In step with international news in recent times, European pharma and biotech are leaning towards ‘nearshoring’, preferring domestic operations to …
-
Machine learning adoption into supply chain management on the horizon
Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years away, …
-
Reflecting on a milestone year for cell and gene therapies
The previous 12 months have seen considerable progress in cell and gene therapies, with the first solid tumor products receiving …
-
Genentech wins FDA approval for second stroke treatment
Genentech has secured a second marketed stroke therapy after the US Food and Drug Administration (FDA) approved a label expansion …
-
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Li predicts that symbiosis between 5G-A and AI technologies will stimulate double-digit growth in both DOU (data of usage) and …
-
EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLC
AstraZeneca's Imfinzi (durvalumab) plus chemotherapy combo has received the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) …
-
MWC Barcelona 2025: Huawei unveils global showcases alongside customers and launches 10 industry solutions with partners
Together with its industry customers, Huawei unveiled 83 global showcases for industrial digital & intelligent transformation for 71 key scenarios. …
-
MWC Barcelona 2025: Huawei unveils global showcases alongside customers and launches 10 industry solutions with partners
Together with its industry customers, Huawei unveiled 83 global showcases for industrial digital & intelligent transformation for 71 key scenarios. …
-
Nuvation Bio secures $250m for taletrectinib commercialisation
Nuvation Bio has secured $250m in non-dilutive financing from Sagard Healthcare Partners to fully fund the commercialisation of taletrectinib in …
-
Using artificial intelligence to enhance regenerative medicine
As the field of regenerative medicine continues to advance, the incorporation of AI is playing a transformative role in the …
-
Novo Nordisk and AI-driven Gensaic enter into $354m cardiometabolic deal
Novo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies for cardiometabolic diseases. The collaboration …
-
EC approves Bavarian Nordic’s chikungunya vaccine marketing
The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine approved in Europe …
-
Ryoncil, the first FDA-approved mesenchymal stromal cell therapy
Regenerative medicine, a rapidly advancing field, can be generally defined as a therapeutic methodology for the repair, regeneration, or replacement …
